Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction

American Journal of Cardiology

Volumn 93, Issue 12, 2004, Pages 1465-1468

  Binbrek, Azan S ^b   Rao, Nayan S ^b   Neimane, Dagnija ^b   Hatou, Eman ^b   Abdulali, Sultan ^b   Sobel, Burton E ^a  

^a University of Vermont Colchester Research Facility   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CREATINE KINASE ISOENZYME; HEPARIN; RECOMBINANT PLASMINOGEN ACTIVATOR; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD SAMPLING; CARDIOGENIC SHOCK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; THORAX PAIN;

ADULT; AGED; ASPIRIN; CREATINE KINASE; CREATINE KINASE, MM FORM; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 2942605843     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.03.004     Document Type: Article

References (29)

1. Keyt B., Paoni N.F., Refino C.J., Berleau L., Nguyen L., Chow A., Lai J., Pena L., Pater C., Ogez J., et al. A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci USA. 91:1994;3670-3674
2. Sobel B.E., Nachowiak D.A., Fry E.T.A., Bergmann S.R., Torr S.R. Paradoxical attenuation of fibrinolysis attributable to "plasminogen steal" and its implications for coronary thrombolysis. Coron Artery Dis. 1:1990;111-119
3. Eisenberg P.R., Sobel B.E., Jaffe A.S. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol. 19:1992;1065-1069
4. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acuter myocardial infarction the ASSENT-2 double-blind randomized trial. Lancet. 354:1999;716-722
5. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682
6. Simes R.J., Topol E.J., Holmes D.R. Jr, White H.D., Rutsch W.R., Vahanian A., Simoons M.L., Morris D., Betriu A., Califf R.M., et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation. 91:1995;1923-1928
7. Bergmann S.R., Fox K.A.A., Ter-Pogossian M.M., Sobel B.E., Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science. 220:1983;1181-1183
8. Van de Werf F., Ludbrook P.A., Bergmann S.R., Tiefenbrunn A.J., Fox K.A.A., deGeest H., Verstraete M., Collen D., Sobel B.E. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med. 310:1984;609-613
9. TIMI Study Group. Special report. The Thrombolysis In Myocardial Infarction (TIMI) trial. N Engl J Med. 32:1985;932-936
10. Eisenberg P.R., Miletich J.P., Sobel B.E. Factors responsible for differential procoagulant effects of diverse plasminogen activators in plasma. Fibrinolysis. 5:1991;217-224
11. Abendschein D.R., Ellis A.K., Eisenberg P.R., Klocke F.J., Sobel B.E., Jaffe A.S. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma. Coron Artery Dis. 2:1991;201-212
12. Hashimoto H., Abendschein D.R., Sobel B.E. Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms. Circulation. 71:1985;363-369
13. Devries S.R., Sobel B.E., Abendschein D.R. Early detection of myocardial reperfusion by assay of plasma MM creatine kinase isoforms in dogs. Circulation. 74:1986;567-572
14. Bergmann S.R., Lerch R.A., Fox K.A.A., Ludbrook P.A., Welch M.J., Ter-Pogossian M.M., Sobel B.E. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med. 73:1982;573-581
15. GISSI Investigators. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1:1986;397-402
16. Weaver W.D., Cerqueira M., Hallstrom A.P., Litwin P.E., Martin J.S., Kudenchuk P.J., Eisenberg M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 270:1993;1211-1216
17. Tiefenbrunn A.J., Sobel B.E. Timing of coronary recanalization. Paradigms, paradoxes, and pertinence. Circulation. 85:1992;2311-2315
18. Zijlstra F., Patel A., Jones M., Grines C.L., Ellis S., Garcia E., Grinfeld L., Gibbons R.J., Ribeiro E.E., Ribichini F., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 23:2002;550-557
19. Berger P.B., Ellis S.G., Holmes D.R. Jr, Granger C.B., Criger D.A., Betriu A., Topol E.J., Califf R.M. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIB) trial. Circulation. 100:1999;14-20
20. Brodie B.R., Kissling G. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Circulation. 102:2000;E29-E30
21. Stent Primary Angioplasty in Myocardial Infarction Study Group, Brodie B.R., Stone G.W., Morice M.C., Cox D.A., Garcia E., Mattos L.A., Boura J., O'Neill W.W., Stuckey T.D., Milks S., et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol. 88:2001;1085-1090
22. Statistical Yearbook 2001. 2001;Dubai Municipality Statistics Center, Dubai, United Arab Emirates
23. Colman P.G., Thomas D.W., Zimmet P.Z., Welborn T.A., Garcia-Webb P., Moore M.P. New classification and criteria for diagnosis of diabetes mellitus. Med J Aust. 170:1999;375-378
24. Roberts R., Henry P.D., Sobel B.E. An improved basis for enzymatic estimation of infarct size. Circulation. 52:1975;743-754
25. Binbrek A., Rao N., Absher P.M., van de Werf F., Sobel B.E. The relative rapidity of recanalization induced by recombinant tissue-type plasminogen (r-tPA) and TNK-tPA, assessed with enzymatic methods. Coron Artery Dis. 11:2000;429-435
26. Abendschein D.R., Serota H., Plummer T.H. Jr, Amiraian D., Strauss A.W., Sobel B.E., Jaffe A.S. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N. J Lab Clin Med. 110:1987;798-806
27. Fox K.A.A., Robison A.K., Knabb R.M., Rosamond T.L., Sobel B.E., Bergmann S.R. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation. 72:1985;1346-1354
28. Dauerman H.L., Sobel B.E. Synergistic treatment of ST segment elevation myocardial infarction with pharmacoinvasive recanalization. J Am Coll Cardiol. 42:2003;646-651
29. Steg P.G., Bonnefoy E., Chabaud S., Lapostolle F., Dubien P.Y., Cristofini P., Leizorovicz A., Touboul P. Impact of time to treatment on mortality after pre-hospital fibrinolysis or primary angioplasty data from the CAPTIM randomized clinical trial. Circulation. 108:2003;2851-2856